Abstract P31: Design and Development of a Novel Anti-BCMA.ECD Antibody for Live Cell Therapy in Multiple Myeloma (MM)
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.fcs2024-p31
Abstract: Multiple myeloma is characterized by the expansion of malignant plasma cells in the bone marrow (BM), which is associated with excessive production of monoclonal immunoglobulins in blood and urine in patients. The addition of monoclonal… read more here.
Keywords: bcma; anti bcma; therapy; bcma ecd ... See more keywords